Status:

RECRUITING

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

Lead Sponsor:

Orchestra BioMed, Inc

Collaborating Sponsors:

Medtronic

Conditions:

Hypertension

Hypertension, Systolic

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-c...

Detailed Description

The study will be conducted in three phases: 1) Screening Phase, 2) Double-blind Randomized Phase (1 year), and 3) Unblinded Phase (2 years). Patients scheduled for implantation of an Astra/Azure pace...

Eligibility Criteria

Inclusion

  • Patient has or is indicated for a dual-chamber pacemaker. Visit 1 can be performed within 30 days prior to a planned implant of a Medtronic Astra/Azure dual-chamber pacemaker system or at any time thereafter
  • On a stable antihypertension treatment regimen with at least 1 class of antihypertensive drug
  • Office SBP ≥135 mmHg and \<180 mmHg
  • Average 24-Hour aSBP ≥130 mmHg and \<170 mmHg

Exclusion

  • LVEF \<50%
  • NYHA Class III-IV
  • History of cerebrovascular accident (CVA) or transient ischemic attack (TIA) within 6 months
  • Myocardial infarction (MI) within 3 months
  • Prior percutaneous or surgical coronary, carotid, or endovascular intervention within 3 months
  • Permanent atrial fibrillation
  • Mitral valve regurgitation greater than or equal to grade 3
  • Aortic stenosis with a valve area less than 1.5 cm2
  • Has an active or prior device-based anti-hypertensive treatment (e.g., renal denervation procedure, baroreflex activation therapy)
  • Has an existing active cardiac device or neurostimulator other than the recent Astra/Azure pacemaker implant

Key Trial Info

Start Date :

December 27 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2029

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT06059638

Start Date

December 27 2023

End Date

August 1 2029

Last Update

December 11 2025

Active Locations (94)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 24 (94 locations)

1

HonorHealth

Scottsdale, Arizona, United States, 85258

2

Adventist Health Glendale

Glendale, California, United States, 91206

3

Stanford

Redwood City, California, United States, 94063

4

Scripps Clinic

San Diego, California, United States, 92121